|
1
|
Cancer International Agency for Research
on Cancer, . Cancer fact sheets. Cancer Today International Agency
for Research on Cancer. World Health Organization; 2020
|
|
2
|
Nagtegaal ID, Odze RD and Klimstra D: WHO
Classification of Tumours, Digestive System. International Agency
for Research on Cancer. Wiley-Blackwell; Lyon: 2019
|
|
3
|
Amin MB, Edge S, Greene F, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: AJCC Cancer Staging Manual. Springer
International Publishing; New York, NY: 2017, View Article : Google Scholar
|
|
4
|
Brierley JD, Gospodarowicz MK and
Wittekind C; Union for International Cancer Control, : TNM
Classification of Malignant Tumours. John Wiley & Sons, Inc.;
Oxford, UK: 2017
|
|
5
|
Kamsa-Ard S, Luvira V, Suwanrungruang K,
Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A,
Bhudhisawasdi V and Pairojkul C: Cholangiocarcinoma trends,
incidence, and relative survival in khon kaen, thailand from 1989
through 2013: A population-based cancer registry study. J
Epidemiol. 29:197–204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Banales JM, Marin JJG, Lamarca A,
Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen
JB, Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in
mechanisms and management. Nat Rev Gastroenterol Hepatol.
17:557–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dodson RM, Weiss MJ, Cosgrove D, Herman
JM, Kamel I, Anders R, Geschwind JF and Pawlik TM: Intrahepatic
cholangiocarcinoma: Management options and emerging therapies. J Am
Coll Surg. 217:736–750.e4. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stowell SR, Ju T and Cummings RD: Protein
glycosylation in cancer. Ann Rev Pathol. 10:473–510. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Varki A, Cummings RD, Esko JD, Stanley P,
Hart GW, Aebi M, Darvill AG, Kinoshita T, Packer NH, Prestegard JH,
et al: Essentials of Glycobiology. 3rd edition. Cold Spring Harbor
Laboratory Press; Cold Spring Harbor, NY: 2015-2017
|
|
10
|
Iwai T, Kudo T, Kawamoto R, Kubota T,
Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K and
Narimatsu H: Core 3 synthase is down-regulated in colon carcinoma
and profoundly suppresses the metastatic potential of carcinoma
cells. Proc Natl Acad Sci USA. 102:4572–4457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwai T, Inaba N, Naundorf A, Zhang Y,
Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H
and Narimatsu H: Molecular cloning and characterization of a novel
UDP-GlcNAc: GalNAc-peptide beta1,3-N Acetylglucosaminyltransferase
(beta 3Gn-T6), an Enzyme Synthesizing the Core 3 Structure of
O-Glycans. J Biol Chem. 277:12802–12809. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SH, Hatakeyama S, Yu SY, Bao X, Ohyama
C, Khoo KH, Fukuda MN and Fukuda M: Core3 O-Glycan synthase
suppresses tumor formation and metastasis of prostate carcinoma PC3
and LNCaP cells through Down-regulation of alha2bata1 Integrin
Complex. J Biol Chem. 284:17157–17169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye J, Wei X, Shang Y, Pan Q, Yang M, Tian
Y, He Y, Peng Z, Chen L, Chen W and Wang R: Core 3 mucin-type
O-glycan restoration in colorectal cancer cells promotes
MUC1/p53/miR-200c-dependent epithelial identity. Oncogene.
36:6391–6407. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pearce OMT: Cancer glycan epitopes:
Biosynthesis, structure and function. Glycobiology. 28:670–696.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Springer GF, Desai PR and Banatwala I:
Blood group MN specific substances and precursors in normal and
malignant human breast tissues. Naturwissenschaften. 61:457–458.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Springer GF: T and Tn, general carcinoma
autoantigens. Science. 224:1198–1206. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chia J, Goh G and Bard F: Short O-GalNAc
glycans: Regulation and role in tumor development and clinical
perspectives. Biochim Biophys Acta. 1860:1623–1639. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hagisawa S, Ohyama C, Takahashi T, Endoh
M, Moriya T, Nakayama J, Arai Y and Fukuda M: Expression of core 2
beta1, 6-N-acetylglucosaminyltransferase facilitates prostate
cancer progression. Glycobiology. 15:1016–1024. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brockhausen I: Mucin-type O-glycans in
human colon and breast cancer: Glycodynamics and functions. EMBO
Rep. 7:599–604. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeh JC, Hiraoka N, Petryniak B, Nakayama
J, Ellies LG, Rabuka D, Hindsgaul O, Marth JD, Lowe JB and Fukuda
M: Novel sulfated lymphocyte homing receptors and their control by
a core1 extension beta 1,3-N-Acetylglucosaminyltransferase. Cell.
105:957–969. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Proteomics, . Tissue-based map of the
human proteome. Science. 347:12604192015.https://www.proteinatlas.org/ENSG00000198488-B3GNT6July
23–2021 View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Angata K, Sawaki H, Tsujikawa S, Ocho M,
Togayachi A and Narimatsu H: Glycogene expression profiling of
hepatic cells by RNA-Seq analysis for Glyco-biomarker
identification. Front Oncol. 10:12242020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ino Y, Yamazaki-Itoh R, Oguro S, Shimada
K, Kosuge T, Zavada J, Kanai Y and Hiraoka N: Arginase II expressed
in cancer-associated fibroblasts indicates tissue hypoxia and
predicts poor outcome in patients with pancreatic cancer. PLoS One.
8:e551462013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Doi N, Ino Y, Angata K, Shimada K,
Narimatsu H and Hiraoka N: Clinicopathological significance of core
3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6
in pancreatic ductal adenocarcinoma. PLoS One. 15:e02428512020.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pinho SS and Reis CA: Glycosylation in
cancer: Mechanisms and clinical implications. Nat Rev Cancer.
15:540–555. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Radhakrishnan P, Grandgenett PM, Mohr AM,
Bunt SK, Yu F, Chowdhury S and Hollingsworth MA: Expression of core
3 synthase in human pancreatic cancer cells suppresses tumor growth
and metastasis. Int J Cancer. 133:2824–2833. 2013.PubMed/NCBI
|
|
27
|
Fu C, Zhao H, Wang Y, Cai H, Xiao Y, Zeng
Y and Chen H: Tumor-associated antigens: Tn antigen, sTn antigen,
and T antigen. HLA. 88:275–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ju T, Wang Y, Aryal RP, Lehoux SD, Ding X,
Kudelka MR, Cutler C, Zeng J, Wang J, Sun X, et al: Tn and
sialyl-Tn antigens, aberrant O-glycomics as human disease markers.
Proteomics Clin Appl. 7:618–631. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Okayama H, Kumamoto K, Saitou K, Hayase S,
Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Koyama Y, et
al: Ectopic expression of MECA-79 as a novel prognostic indicator
in gastric cancer. Cancer Sci. 102:1088–1094. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Steentoft C, Yang Z, Wang S, Ju T,
Vester-Christensen MB, Festari MF, King SL, Moremen K, Larsen ISB,
Goth CK, et al: A validated collection of mouse monoclonal
antibodies to human glycosyltransferases functioning in mucin-type
O-glycosylation. Glycobiology. 29:645–656. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dondossola D, Ghidini M, Grossi F, Rossi G
and Foschi D: Practical review for diagnosis and clinical
management of perihilar cholangiocarcinoma. World J Gastroenterol.
26:3542–3561. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aryal RP, Ju T and Cummings RD: The
endoplasmic reticulum chaperone cosmc directly promotes in vitro
folding of T-synthase. J Biol Chem. 285:2456–2462. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gupta R, Leon F, Rauth S, Batra SK and
Ponnusamy MP: A systematic review on the implications of O-linked
glycan branching and truncating enzymes on cancer progression and
metastasis. Cells. 9:4462020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoshino H, Ohta M, Ito M, Uchimura K,
Sakai Y, Uehara T, Low S, Fukushima M and Kobayashi M: Apical
membrane expression of distinct sulfated glycans represents a novel
marker of cholangiolocellular carcinoma. Lab Invest. 96:1246–1255.
2016. View Article : Google Scholar : PubMed/NCBI
|
